# Amylyx Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 29, 2022

- Company: [Amylyx Pharmaceuticals, Inc.](/companies/amlx.md) (CIK 1658551)
- Form: DEF 14A
- Filed: 2022-04-29
- Accepted by EDGAR: Apr 29, 2022, 07:04 ET
- Period: 2022-06-09
- Accession: 0001193125-22-130050
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1658551/000119312522130050/d235425ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1658551/000119312522130050/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1658551/000119312522130050/d235425ddef14a.htm

Filed Apr 29, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-130050. Last ingested by Listed: Nov 13, 2026, 14:43 ET. No prices; not investment advice.
